THYROID HORMONE RECEPTOR ON MACROPHAGES AMELIORATE IL1 RECEPTOR=ASSOCIATED KIDNEY FIBROSIS Shikata, M., Furuya, F., Kitamura, K. 第53回 ERA-EDTA 2016年5月Austria
ASSOCIATION OF SERUM OMENTIN WITH A MARKER OF PROGRESSION OF DIABETIC NEPHROPATHY Takeda-Koh, R., Furuya, F., Kobayashi, H., Kitamura, K. 第53回 ERA-EDTA 2016年5月Austria
SKIN AUTOFLUORESCENCE IS A PREDICTOR OF PROGRESSION OF DIABETIC COMPLICATIONS Oku, T., Furuya, F., Haraguchi, K., Kitamura, K. 第53回ERA-EDTA 2016年5月Austria
EFFICACY OF FEBUXOSTAT IN TYPE 2 DIABETIC PATIENTS WITH KIDNEY IMPAIRMENT Akiyama, D., Furuya, F., Wakasugi, M., Kitamura, K. 第53回 ERA-EDTA 2016年5月Austria
Thyroid Hormone Receptor on Macrophages Ameliorate Kidney Injury via Inhibition of Nuclear Factor-κB Activities Ishii, T., Furuya, F., Kitamura, K., Ligand-Bound American society of nephrology KIDNEY WEEK 2016 2016年11月CHICAGO
Two cases of adult onset IgA vasculitis with acute kidney injury and severe gastrointestinal manifestations:Successful treatment with factor XIII supplement Takamura, T., Furuya, F., Kitamura, K. American society of nephrology KIDNEY WEEK 2016 2016年11月CHICAGO
Omentin1 regulates podocyte function and albuminuria Kobayashi, H., Furuya, F., Kitamura, K. American society of nephrology KIDNEY WEEK 2016 2016年11月CHICAGO
Rabbit Monoclonal Antibody (RabMAb) Validation in Mouse and Human Kidney Kohei Uchimura and Benjamin D. Humphreys RBK (ReBuilding a Kidney) executive meeting, Chicago, 2016 November
The ligand-bound thyroid hormone receptor in macrophages ameliorates kidney injury via inhibition of nuclear factor-κB activities Furuya, F., Ishii, T., Tamura, S., Takahashi, K., Kobayashi, H., Ichijo, M., Takizawa, S., Kaneshige, M., Suzuki-Inoue, K., Kitamura, K. Sci Rep. Mar 8;7: 2017
An anti-deoxyhypusine synthase antibody as a marker of atherosclerosis-related cerebral infarction, myocardial infarction, diabetes mellitus, and chronic kidney disease. Nakamura, R., Tomiyoshi, G., Shinmen, N., Kuroda, H., Kudo, T., Doi, H., Mine, S., Machida, T., Kamitsukasa, I., Wada, T., Aotsuka, A., Kobayashi, E., Yoshida, Y., Matsutan, T., Iwadate, Y., Mori, M., Uzawa, A., Muto, M., Sugimoto, K., Kuwabara, S., Takemoto, M., Hattori, A., Kobayashi, K., Awamura, H., Ishibashi, R., Yokote, K., Iwata, Y., Harada, J., Kobayashi, Y., Terada, J., Matsumura, T., Sakao, S., Tatsumi, K., Ohno, M., Chen, P. M., Nishi, E., Ono, K., Kimura, T., Kitamura, K., Takizawa, H., Kashiwado, K., Shimada, H., Ito, M., Goto, K., Zhang, X. M., Kimura, R., Wang, H., Taira, A., Arita, E., Shino, H., Iwase, K., and Hiwasa, T SM Atheroscler J. 2017; 1(1):
Pharmacological and genetic reappraisals of protease and oxidative stress pathways in a mouse model of obstructive lung diseases. Shuto, T., Kamei, S., Nohara, H., Fujikawa, H., Tasaki, Y., Sugahara, T., Ono, T., Matsumoto, C., Sakaguchi, Y., Maruta, K., Nakashima, R., Kawakami, T., Suico, M. A., Kondo, Y., Ishigami, A., Takeo, T., Tanaka, K.-I., Watanabe, H., Nakagata, N., Uchimura, K., Kitamura, K., Li, J. D., and Kai, H. Sci. Rep. 6: 39305, 2016
A serine protease inhibitor attenuates aldosterone-induced kidney injury via the suppression of plasmin activity. Kakizoe, Y., Miyasato, Y., Onoue, T., Nakagawa, T., Hayata, M., Uchimura, K., Morinaga, J., Adachi, M., Miyoshi, T., Sakai, Y., Tomita, K., Mukoyama, M., and Kitamura, K. J. Pharmacol. Sci. 132: 145-153, 2016
Mild systemic thermal therapy ameliorates renal dysfunction in a rodent model of chronic kidney disease. Iwashita, Y., Kuwabara, T., Hayata, M., Kakizoe, Y., Izumi, Y., Iiyama, J., Kitamura, K., and Mukoyama, M. Am. J. Physiol. (Renal Physiol.) 310: F1206-1215, 2016
ESA Hyporesponsiveness Is Associated with Adverse Events in Maintenance Hemodialysis (MHD) Patients, But Not with Iron Storage. Kuragano, T., Kitamura, K., Matsumura, O., Matsuda, A., Hara, T., Kiyomoto, H., Murata, T., Fujimoto, S., Hase, H., Joki, N., Fukatsu, A., Inoue, T., Itakura, Y., and Nakanishi, T. PLoS One 11: e0147328, 2016
Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model. Narita, Y., Ueda, M., Uchimura, K., Kakizoe, Y., Miyasato, Y., Mizumoto, T., Morinaga, J., Hayata, M., Nakagawa, T., Adachi, M., Miyoshi, T., Sakai, Y., Kadowaki, D., Hirata, S., Mukoyama, M., and Kitamura, K. J. Pharmacol. Sci. 130: 110-116, 2016
Angiopoietin-like protein 2 increases renal fibrosis by accelerating transforming growth factor-β signaling in chronic kidney disease. Morinaga, J., Kadomatsu, T., Miyata, K., Endo, M., Terada, K., Tian, Z., Sugizaki, T., Tanigawa, H., Zhao, J., Zhu, S., Sato, M., Araki, K., Iyama, K., Tomita, K., Mukoyama, M., Tomita, K., Kitamura, K., and Oike, Y. Kidney Int. 89: 327-341, 2016
Successful treatment of rapidly progressive Immunoglobulin A nephropathy with human immunodeficiency virus infection by steroid pulse therapy and tonsillectomy Miyasato, Y., Miyoshi, T., Fujimoto, D., Adachi, M., Kitamura, K., and Mukoyama, M. Nephrology 21: 159-160, 2016
受賞
石井 俊史：Kidney Summit 2016 奨励賞 2016年12月
助成金
内村 幸平：日本学術振興会 海外特別研究員
内村 幸平：ASN Campbell Fellows Travel Support Travel Grant
